Log In
BCIQ
Print this Print this
 

MCLA-114

  Manage Alerts
Collapse Summary General Information
Company Merus N.V.
DescriptionHuman bispecific IgG antibody targeting CD3 expressed by T cells and an undisclosed target expressed by multiple myeloma cells
Molecular Target CD3
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today